✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹2,397 Cr.
P/E
35.60

Key Ratios

Market cap
Market cap
2,397 Cr
PE
PE
35.60
Prom Holding
Prom Holding
54.87 %
ROE (%)
ROE (%)
15.09
ROCE (%)
ROCE (%)
23.18
Div Yield (%)
Div Yield (%)
-
Sales
Sales
503 Cr
OPM (%)
OPM (%)
23.50 %
Debt to Equity
Debt to Equity
0.43
Institutions
Institutions
3.15 %
Individual < 2 lac
Individual < 2 lac
14.61 %
No. of Shareholders
No. of Shareholders
10,555

About

Kwality Pharmaceuticals Ltd. is a pharmaceutical formation company specializing in manufacturi… Read more
Low
829
52W Range
High
2351
  • Kwality Pharma
  • Unichem Lab
  • Panacea Biotec

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Segment Break-Up

Formulations Breakup

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Kwality Pharmaceuticals Ltd. Business

Kwality Pharmaceuticals Ltd. is a pharmaceutical formation company manufacturing and exporting finished pharmaceutical formulations in various dosage forms since 1983, following new GMP norms.

Kwality Pharma major competitors are Unichem Lab, Panacea Biotec, Indoco Remedies, Sakar Healthcare, Venus Remedies, Beta Drugs, Gufic Biosciences.
Market Cap of Kwality Pharma is ₹2,397 Crs.
While the median market cap of its peers are ₹1,935 Crs.

Kwality Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Dec Mar Jun Sep
Investor Presentation Feb May Jun Mar May Mar Jun Mar May
Conference Call May
Conference Call SummaryCon Call Summary

Discussions & Analysis

Kwality Pharmaceuticals Ltd.
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material